$78.36
+2.5%Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Chief Communications & Brand Officer
Chief Executive Officer & Director
Compensation
$10,370,481
Chief Financial Officer
Compensation
$1,557,992
Chief Human Resources Officer
Compensation
$1,119,093
Chief Information & Digital Officer
Compensation
$2,319,204
Chief Legal Affairs Officer & Corporate Secretary
Chief Strategy & Corporate Development Officer
Executive Vice President & Group President of Medical Surgical
Compensation
$1,763,436
Senior Vice President of Investor Relations & External Finance Communications
Senior Vice President, Corporate Controller & Chief Accounting Officer
During the last 12 months, insiders have purchased $100K and sold $646.36M worth of SOLV shares, resulting in $646.26M of net selling activity.
1.5K
100.34K
0
0.00
+100K
+$100K
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
8.8M
646.36M
-646.4M
-$646.36M
Wendell Amy Mcbride
Director
$100K
3M Co
10 Percent Owner
$646.36M
Strong bearish signal with $646.26M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
1 insider buyers and 1 sellers. Equal participation suggests mixed or neutral insider views.
SOLV - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | March 27, 2026 | December 31, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 21, 2025 | December 31, 2024 | 2024 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.